Our full coverage of the meeting is now live so dive in here: bit.ly/3SUQCOX.
Staying up to date with cutting-edge scientific research isn’t just important, it’s essential. #immunotherapy
Our full coverage of the meeting is now live so dive in here: bit.ly/3SUQCOX.
Staying up to date with cutting-edge scientific research isn’t just important, it’s essential. #immunotherapy
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
👉 Go to bit.ly/3SUQCOX to read a summary of select talks. #CIMT2025 Featured are: @ki.se @unileiden.bsky.social @ethz.ch @niaidnews.bsky.social @dkfz.bsky.social @lukasbunse.bsky.social @biontech.bsky.social
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
#CancerImmunotherapy #PrecisionMedicine
#CancerImmunotherapy #PrecisionMedicine
#CancerImmunotherapy #Immunometabolism
#CancerImmunotherapy #Immunometabolism